NCT05826535 2026-04-17Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaLyell Immunopharma, Inc.Phase 1/2 Recruiting270 enrolled
NCT03328078 2026-04-16CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Curis, Inc.Phase 1/2 Recruiting152 enrolled
NCT07216443 2026-04-15Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeOrca Biosystems, Inc.Phase 2 Recruiting80 enrolled
NCT03922724 2026-03-30Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting330 enrolled